Skip to main content
. 2022 Jan 13;24(7):1119–1126. doi: 10.1093/europace/euab315

Table 1.

Univariate association with pericardial effusion

Characteristic Effusion (N = 32) No effusion (N = 2785) Odds ratio (95% CI) P-value
Body mass index 25.7 ± 6.0 (32) 27.8 ± 5.7 (2741) 0.92 (0.86–1.00) 0.038
BMI <20 kg/m2 15.6% (5/32) 4.3% (117/2741) 4.15 (1.57–10.98) 0.004
Age (years) 78.4 ± 13.6 (32) 75.7 ± 12.7 (2782) 1.02 (0.99–1.06) 0.229
Age ≥75 65.6% (21/32) 65.0% (1809/2782) 1.03 (0.49–2.14) 0.944
Age ≥85 46.9% (15/32) 23.2% (646/2782) 2.92 (1.45–5.87) 0.003
Female 62.5% (20/32) 39.6% (1103/2783) 2.54 (1.24–5.21) 0.011
Cardiomyopathy 15.6% (5/32) 15.3% (427/2783) 1.02 (0.39–2.67) 0.965
Congestive heart failure 28.1% (9/32) 15.6% (433/2783) 2.12 (0.98–4.62) 0.058
Coronary artery disease 15.6% (5/32) 25.2% (702/2783) 0.55 (0.21–1.43) 0.220
Myocardial infarction 15.6% (5/32) 8.8% (246/2783) 1.91 (0.73–5.00) 0.188
Hypertension 68.8% (22/32) 69.8% (1942/2783) 0.95 (0.45–2.02) 0.900
Pulmonary hypertension 12.5% (4/32) 7.9% (220/2783) 1.66 (0.58–4.79) 0.345
Coronary artery intervention 18.8% (6/32) 14.8% (411/2783) 1.33 (0.55–3.26) 0.529
COPD 28.1% (9/32) 11.2% (313/2783) 3.09 (1.42–6.73) 0.005
Diabetes 28.1% (9/32) 27.5% (764/2783) 1.03 (0.48–2.25) 0.932
Preclusion for transvenous pacing 18.8% (6/32) 19.4% (540/2782) 0.96 (0.39–2.34) 0.925
AF history 50.0% (16/32) 72.9% (2028/2783) 0.37 (0.19–0.75) 0.006
Prior cardiac surgery 12.5% (4/32) 24.8% (690/2783) 0.43 (0.15–1.24) 0.119
On OAC 67.7% (21/31) 73.5% (2036/2769) 0.76 (0.35–1.61) 0.469
Renal dysfunction (any) 25.0% (8/32) 21.5% (597/2783) 1.22 (0.55–2.73) 0.627
Renal dysfunction (dialysis required) 12.5% (4/32) 7.0% (195/2783) 1.90 (0.66–5.46) 0.236

AF, atrial fibrillation; BMI, body mass index; CI, confidence interval; COPD, chronic obstructive pulmonary disease; OAC, oral anticoagulation.